If not stabilised by use of special substances, nanoobjects, and also carbon nanotubes, tend to agglutinate very rapidly. The agglomerates can be larger than one cell. Under such conditions, the cells would rather “choke” on (frustrated phagocytosis) than take up carbon nanotubes. Smaller agglomerates are taken up by the cells via pinocytosis (cell drinking) and can be detected by means of TEM (Transmission Electron Microscopy) in cell inclusions (so-called vesicles). The vesicle membrane protects the remaining cell components from the carbon nanoparticles, i.e. although being in the cell, the particles are still encapsulated. However, a topical study shows that CNT may well be able to escape from such encapsulations (compartments) to get into the cytoplasm, which is the liquid interior of the cell[3].
Functionalised carbon nanotubes (fCNT), which can penetrate the biological barriers due to modified surface properties, are of great interest to medical and biotechnological applications. fCNT, in contrast to non-modified CNT, do not agglutinate in aqueous environment and can be available as individual tubes[2]. Due to their shapes and sizes, fCNT can take an alternative, vesicle-independent path into the cells. Present research wants to throw light on this uptake mechanism and its implications as regards nanomaterials.
It has not yet been adequately explained so far on which path the CNT leave the cells again and whether they are accumulated in the cells.
Literature
-
Conner SD and Schmid SL 2003, Nature 422(6927): 37-44
-
Kostarelos K et al 2007, Nat Nanotechnol 2: 108-113
-
Mu Q et al 2009, Nano Lett 9(12): 4370-4375.